Dr. Timothy Miller, Washington University, and Dr. Merit Cudkowicz, Massachusetts General Hospital, provide an update on the C9orf72 Natural History Study and discuss therapies in development for C9 patients. Steve Kolb, patient advocate, describes the motivation behind the project and explains how you can get involved.
C9: From ID (Identification) to Therapy from Northeast ALS Consortium on Vimeo.